Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5

被引:20
作者
Downey, L. M.
Bottomley, H. M.
Sheridan, E.
Ahmed, M.
Gilmour, D. F.
Inglehearn, C. F.
Reddy, A.
Agrawal, A.
Bradbury, J.
Toomes, C. [1 ]
机构
[1] St Jamess Univ Hosp, Leeds Inst Mol Med, Dept Clin Genet, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England
[2] Gen Infirm, Dept Ophthalmol, Leeds LS1 3EX, W Yorkshire, England
[3] Univ Leeds, Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS2 9JT, W Yorkshire, England
[4] Bradford Royal Infirm, Dept Ophthalmol, Bradford BD9 6RJ, W Yorkshire, England
基金
英国惠康基金;
关键词
D O I
10.1136/bjo.2006.092114
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background/aims: Familial exudative vitreoretinopathy (FEVR) is an inherited blinding condition characterised by abnormal development of the retinal vasculature. FEVR has multiple modes of inheritance, and homozygous mutations in LRP5 have recently been reported as underlying the recessive form of this disease. The aim of this study was to examine LRP5 in a consanguineous recessive FEVR family and to clarify the eye and bone phenotype associated with recessive FEVR. Methods: All family members were examined by slit lamp biomicroscopy and indirect ophthalmoscopy. Linkage to LRP5 was determined by genotyping microsatellite markers, constructing haplotypes and calculating lod scores. Mutation screening of LRP5 was performed by polymerase chain reaction amplification of genomic DNA followed by direct sequencing. Bone mineral density (BMD) was evaluated in all family members using dual energy x ray absorptiometry (DEXA). Results: The clinical features observed in this family were consistent with a diagnosis of recessive FEVR. A homozygous LRP5 missense mutation, G550R, was identified in all affected individuals and all unaffected family members screened were heterozygous carriers of this mutation. Reduced BMD, hyaloid vasculature remnants, and nystagmus were features of the phenotype. Conclusion: Recessive mutations in LRP5 can cause FEVR with reduced BMD and hyaloid vasculature remnants. Assessment of a patient with a provisional diagnosis of FEVR should therefore include investigation of BMD, with reduced levels suggestive of an underlying LRP5 mutation.
引用
收藏
页码:1163 / 1167
页数:5
相关论文
共 34 条
[1]   Clinical and molecular findings in osteoporosis-pseudoglioma syndrome [J].
Ai, MR ;
Heeger, S ;
Bartels, CF ;
Schelling, DK .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 77 (05) :741-753
[2]  
Benson W E, 1995, Trans Am Ophthalmol Soc, V93, P473
[3]   High bone density due to a mutation in LDL-receptor-related protein 5 [J].
Boyden, LM ;
Mao, JH ;
Belsky, J ;
Mitzner, L ;
Farhi, A ;
Mitnick, MA ;
Wu, DQ ;
Insogna, K ;
Lifton, RP .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (20) :1513-1521
[4]   Familial exudative vitreoretinopathy mimicking persistent hyperplastic primary vitreous [J].
Chang-Godinich, A ;
Paysse, EA ;
Coates, DK ;
Holz, ER .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1999, 127 (04) :469-471
[5]   A MUTATION IN THE NORRIE DISEASE GENE (NDP) ASSOCIATED WITH X-LINKED FAMILIAL EXUDATIVE VITREORETINOPATHY [J].
CHEN, ZY ;
BATTINELLI, EM ;
FIELDER, A ;
BUNDEY, S ;
SIMS, K ;
BREAKEFIELD, XO ;
CRAIG, IW .
NATURE GENETICS, 1993, 5 (02) :180-183
[6]   FAMILIAL EXUDATIVE VITREORETINOPATHY [J].
CRISWICK, VG ;
SCHEPENS, CL .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1969, 68 (04) :578-&
[7]   Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity [J].
de Crecchio, G ;
Simonelli, F ;
Nunziata, G ;
Mazzeo, S ;
Greco, GM ;
Rinaldi, E ;
Ventruto, V ;
Ciccodicola, A ;
Miano, MG ;
Testa, F ;
Curci, A ;
D'Urso, M ;
Rinaldi, MM ;
Cavaliere, ML ;
Castelluccio, P .
CLINICAL GENETICS, 1998, 54 (04) :315-320
[8]   A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13 [J].
Downey, LM ;
Keen, TJ ;
Roberts, E ;
Mansfield, DC ;
Bamashmus, M ;
Inglehearn, CF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) :778-781
[9]  
DUDGEON J, 1979, T OPHTHAL SOC UK, V99, P45
[10]   Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass [J].
Ferrari, SL ;
Deutsch, S ;
Antonarakis, SE .
CURRENT OPINION IN LIPIDOLOGY, 2005, 16 (02) :207-213